User profiles for FranÇois Lamontagne

Francois Lamontagne

Université de Sherbrooke
Verified email at USherbrooke.ca
Cited by 27052

[HTML][HTML] Intravenous vitamin C in adults with sepsis in the intensive care unit

F Lamontagne, MH Masse, J Menard… - … England Journal of …, 2022 - Mass Medical Soc
Background Studies that have evaluated the use of intravenous vitamin C in adults with
sepsis who were receiving vasopressor therapy in the intensive care unit (ICU) have shown …

Critically ill patients with 2009 influenza A (H1N1) infection in Canada

…, T Stelfox, S Bagshaw, K Choong, F Lamontagne… - Jama, 2009 - jamanetwork.com
Context Between March and July 2009, the largest number of confirmed cases of 2009
influenza A(H1N1) infection occurred in North America. Objective To describe characteristics, …

Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: a randomized clinical trial

F Lamontagne, A Richards-Belle, K Thomas… - Jama, 2020 - jamanetwork.com
Importance Vasopressors are commonly administered to intensive care unit (ICU) patients
to raise blood pressure. Balancing risks and benefits of vasopressors is a challenge, …

A living WHO guideline on drugs for covid-19

…, BJ Hunt, M Stegemann, B Rochwerg, F Lamontagne… - bmj, 2020 - bmj.com
Updates This is the fourteenth version (thirteenth update) of the living guideline, replacing
earlier versions (available as data supplements). New recommendations will be published as …

Effect of probiotics on incident ventilator-associated pneumonia in critically ill patients: a randomized clinical trial

…, HT Stelfox, D Niven, J Muscedere, F Lamontagne… - Jama, 2021 - jamanetwork.com
Importance Growing interest in microbial dysbiosis during critical illness has raised
questions about the therapeutic potential of microbiome modification with probiotics. Prior …

Drug treatments for covid-19: living systematic review and network meta-analysis

…, JPD Martinez, A Izcovich, B Rochwerg, F Lamontagne… - bmj, 2020 - bmj.com
Objective To compare the effects of treatments for coronavirus disease 2019 (covid-19).
Design Living systematic review and network meta-analysis. Data sources WHO covid-19 …

Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis

…, C Green, R Haniffa, N Ichihara, F Lamontagne… - Jama, 2021 - jamanetwork.com
Importance Clinical trials assessing the efficacy of IL-6 antagonists in patients hospitalized
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …

A living WHO guideline on drugs for covid-19

A Agarwal, B Rochwerg, F Lamontagne… - 2022 - scholar.sun.ac.za
This living guideline by Arnav Agarwal and colleagues (BMJ 2020; 370: m3379, doi: 10.1136/bmj.
m3379) was last updated on 22 April 2022, but the infographic contained two dosing …

Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain

F Lamontagne, AC Labbé, O Haeck, O Lesur… - Annals of …, 2007 - journals.lww.com
Objectives: To determine whether emergency colectomy reduces mortality in patients with
fulminant Clostridium difficile-associated disease (CDAD), and to identify subgroups of …

[HTML][HTML] Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis

…, SM Pastores, J Marshall, F Lamontagne… - Intensive care …, 2021 - Springer
Purpose Corticosteroids are now recommended for patients with severe COVID-19 including
those with COVID-related ARDS. This has generated renewed interest regarding whether …